Cargando…

Prognostic Factors for Overall Survival in Patients with HCV-Related HCC Undergoing Molecular Targeted Therapies: Beyond a Sustained Virological Response

SIMPLE SUMMARY: The eradication of the hepatitis C virus (HCV) has had a significant impact on the management of patients with HCV-related hepatocellular carcinoma (HCC). However, its eradication has not completely resolved survival issues in patients with HCV-related HCC. Therefore, the present stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minami, Yasunori, Aoki, Tomoko, Chishina, Hirokazu, Takita, Masahiro, Hagiwara, Satoru, Ida, Hiroshi, Ueshima, Kazuomi, Nishida, Naoshi, Kudo, Masatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562238/ https://www.ncbi.nlm.nih.gov/pubmed/36230773 http://dx.doi.org/10.3390/cancers14194850

Ejemplares similares

Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma
por: Nishida, Naoshi, et al.
Publicado: (2023)

Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma
por: Morita, Masahiro, et al.
Publicado: (2023)

Exploratory Analysis of Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma Who Have Failed Prior PD−1/PD-L1 Checkpoint Blockade
por: Aoki, Tomoko, et al.
Publicado: (2020)

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
por: Hagiwara, Satoru, et al.
Publicado: (2021)

Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study
por: Ueshima, Kazuomi, et al.
Publicado: (2019)

Role of phlebotomy in the treatment of liver damage related to erythropoietic porphyria
por: Hagiwara, Satoru, et al.
Publicado: (2022)

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study
por: Kudo, Masatoshi, et al.
Publicado: (2019)

Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study
por: Kudo, Masatoshi, et al.
Publicado: (2023)

Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host disease
por: Hagiwara, Satoru, et al.
Publicado: (2021)

Cases with Refractory Ascites and a Delayed Response to Tolvaptan
por: Hagiwara, Satoru, et al.
Publicado: (2016)

Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma
por: Arizumi, Tadaaki, et al.
Publicado: (2014)

Unique Association between Global DNA Hypomethylation and Chromosomal Alterations in Human Hepatocellular Carcinoma
por: Nishida, Naoshi, et al.
Publicado: (2013)

A case of HCC successfully treated with infliximab‐steroid sequential therapy for small bowel perforation due to atezolizumab/bevacizumab combination therapy
por: Hagiwara, Satoru, et al.
Publicado: (2022)

Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma
por: Minami, Yasunori, et al.
Publicado: (2023)

Cold-inducible RNA-binding protein promotes the development of liver cancer
por: Sakurai, Toshiharu, et al.
Publicado: (2015)

Imaging Diagnosis of Various Hepatocellular Carcinoma Subtypes and Its Hypervascular Mimics: Differential Diagnosis Based on Conventional Interpretation and Artificial Intelligence
por: Minami, Yasunori, et al.
Publicado: (2022)

Advances in Immunotherapy for Hepatocellular Carcinoma
por: Hagiwara, Satoru, et al.
Publicado: (2023)

Clinical Significance of the Duality of Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma
por: Aoki, Tomoko, et al.
Publicado: (2022)

Three-Dimensional Radiological Assessment of Ablative Margins in Hepatocellular Carcinoma: Pilot Study of Overlay Fused CT/MRI Imaging with Automatic Registration
por: Minami, Yasunori, et al.
Publicado: (2021)

Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy
por: Nishida, Naoshi, et al.
Publicado: (2018)

The Efficacy of Sonazoid-enhanced Ultrasonography in Decision-making for Liver Abscess Treatment
por: Morita, Masahiro, et al.
Publicado: (2020)

Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma
por: Sakurai, Toshiharu, et al.
Publicado: (2017)

Verrucous antral gastritis in relation to Helicobacter pylori infection, nutrition, and gastric atrophy
por: Tsuji, Naoko, et al.
Publicado: (2019)

Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesis
por: Hagiwara, Satoru, et al.
Publicado: (2017)

Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma
por: Nishida, Naoshi, et al.
Publicado: (2020)

Artificial Intelligence in Medical Imaging and Its Application in Sonography for the Management of Liver Tumor
por: Nishida, Naoshi, et al.
Publicado: (2020)

Artificial intelligence models for the diagnosis and management of liver diseases
por: Nishida, Naoshi, et al.
Publicado: (2023)

Problems of Long Survival Following Surgery in Patients with NonBNonC-HCC: Comparison with HBV and HCV Related-HCC
por: Hiwatashi, Kiyokazu, et al.
Publicado: (2015)

Long-Term Survival of More than 5 Years with Maintenance Therapy Using Single-Agent Pemetrexed in a Patient with Diffuse Malignant Peritoneal Mesothelioma
por: Otsuka, Yasuo, et al.
Publicado: (2023)

Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review
por: Minami, Yasunori, et al.
Publicado: (2011)

Radiofrequency Ablation of Liver Metastases from Colorectal Cancer: A Literature Review
por: Minami, Yasunori, et al.
Publicado: (2013)

Image Guidance in Ablation for Hepatocellular Carcinoma: Contrast-Enhanced Ultrasound and Fusion Imaging
por: Minami, Yasunori, et al.
Publicado: (2021)

Virologic Tools for HCV Drug Resistance Testing
por: Fourati, Slim, et al.
Publicado: (2015)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients
por: Yutani, Shigeru, et al.
Publicado: (2015)

Erythropoietic Protoporphyria-related Hepatopathy Successfully Treated with Phlebotomy
por: Yoshida, Akihiro, et al.
Publicado: (2018)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections
por: Manickam, Cordelia, et al.
Publicado: (2014)

Interleukin-6 polymorphisms in HCC patients chronically infected with HCV
por: Adnan, Faisal, et al.
Publicado: (2020)

CD8(+) T Cell Responses during HCV Infection and HCC
por: Hofmann, Maike, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m8f9u4e8k3356ivmomuuijkhbc